Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbazoles | 6 | 2018 | 42 | 1.420 |
Why?
|
| rac1 GTP-Binding Protein | 7 | 2021 | 46 | 1.200 |
Why?
|
| Pyrimidines | 6 | 2017 | 118 | 1.130 |
Why?
|
| Drug Design | 3 | 2018 | 162 | 1.000 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2022 | 22 | 0.900 |
Why?
|
| Aminoquinolines | 3 | 2013 | 14 | 0.520 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 803 | 0.520 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 433 | 0.480 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2023 | 52 | 0.410 |
Why?
|
| Warfarin | 2 | 2023 | 64 | 0.400 |
Why?
|
| Drug Industry | 1 | 2009 | 14 | 0.350 |
Why?
|
| cdc42 GTP-Binding Protein | 2 | 2021 | 23 | 0.340 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 1502 | 0.290 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 28 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2009 | 400 | 0.250 |
Why?
|
| p21-Activated Kinases | 2 | 2013 | 16 | 0.230 |
Why?
|
| Glucose | 2 | 2015 | 230 | 0.230 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 60 | 0.210 |
Why?
|
| Crystallization | 1 | 2021 | 86 | 0.200 |
Why?
|
| Cell Movement | 3 | 2022 | 571 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2231 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1198 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2015 | 6 | 0.160 |
Why?
|
| Binding Sites | 2 | 2018 | 651 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 408 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 409 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 127 | 0.140 |
Why?
|
| Animals | 9 | 2023 | 15081 | 0.140 |
Why?
|
| Humans | 11 | 2023 | 37093 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 95 | 0.130 |
Why?
|
| Mice | 6 | 2023 | 5913 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 219 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 14 | 0.120 |
Why?
|
| Cell Survival | 4 | 2023 | 864 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 211 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 30 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 236 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 182 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 421 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2023 | 102 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 113 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 730 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 502 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2009 | 42 | 0.090 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2023 | 14 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2015 | 444 | 0.060 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 29 | 0.050 |
Why?
|
| Cell Division | 1 | 2022 | 307 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2023 | 399 | 0.050 |
Why?
|
| Phase Transition | 1 | 2021 | 9 | 0.050 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2021 | 30 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2021 | 57 | 0.050 |
Why?
|
| Cell Line | 2 | 2015 | 1354 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2021 | 150 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 152 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 265 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 1618 | 0.050 |
Why?
|
| Female | 4 | 2021 | 20969 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 1908 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1371 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 2015 | 12 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 110 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 148 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 275 | 0.030 |
Why?
|
| Mastocytosis | 1 | 2013 | 2 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 337 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 84 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 562 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2013 | 83 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 409 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 259 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 461 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 22 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 935 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 295 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3483 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1398 | 0.020 |
Why?
|
| Male | 2 | 2015 | 20025 | 0.020 |
Why?
|